fda bpc 157 category 2 bulk drug substance compounding list The U.S. Food and Administration is moving toward allowing pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy in Austin, TX
Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA Peptide Reclassification 2026: What It Means for Providers
Pay in 4 interest-free payments of $7.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8


